These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 18190624)

  • 1. Re-operation rates after permanent sacral nerve stimulation for refractory voiding dysfunction in women.
    Blandon RE; Gebhart JB; Lightner DJ; Klingele CJ
    BJU Int; 2008 May; 101(9):1119-23. PubMed ID: 18190624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sacral nerve stimulation for voiding dysfunction: One institution's 11-year experience.
    Sutherland SE; Lavers A; Carlson A; Holtz C; Kesha J; Siegel SW
    Neurourol Urodyn; 2007; 26(1):19-28; discussion 36. PubMed ID: 17078071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical Results of PNE Tests in 70 Patients with Different Bladder Dysfunctions].
    Braun PM; Eckermann J; Bross S; Martinez-Portillo FJ; Jünemann KP; Seif C
    Aktuelle Urol; 2003 May; 34(3):162-5. PubMed ID: 14566687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of permanent electrodes in the peripheral nerve evaluation test (PNE-Test) in comparison to conventional wire electrodes].
    Seif C; Bannowsky A; Wefer B; Naumann VC; van der Horst C; Jünemann KP; Braun PM
    Aktuelle Urol; 2006 Jul; 37(4):277-80. PubMed ID: 16878281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sacral nerve stimulation for treatment of refractory urinary retention: long-term efficacy and durability.
    White WM; Dobmeyer-Dittrich C; Klein FA; Wallace LS
    Urology; 2008 Jan; 71(1):71-4. PubMed ID: 18242368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sacral nerve stimulator revision due to somatic growth.
    Clark C; Ngo T; Comiter CV; Anderson R; Kennedy W
    J Urol; 2011 Oct; 186(4 Suppl):1576-80. PubMed ID: 21855923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New screening technique for sacral nerve stimulation under local anaesthesia.
    Hetzer FH; Hahnloser D; Knoblauch Y; Löhlein F; Demartines N
    Tech Coloproctol; 2005 Apr; 9(1):25-8. PubMed ID: 15868495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medium-term experience of sacral neuromodulation by tined lead implantation.
    Van Voskuilen AC; Oerlemans DJ; Weil EH; van den Hombergh U; van Kerrebroeck PE
    BJU Int; 2007 Jan; 99(1):107-10. PubMed ID: 16956350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PNE versus 1st stage tined lead procedure: a direct comparison to select the most sensitive test method to identify patients suitable for sacral neuromodulation therapy.
    Leong RK; De Wachter SG; Nieman FH; de Bie RA; van Kerrebroeck PE
    Neurourol Urodyn; 2011 Sep; 30(7):1249-52. PubMed ID: 21404317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sacral neuromodulation in urological indications: the Finnish experience.
    Vaarala MH; Tammela TL; Perttilä I; Luukkonen P; Hellström P
    Scand J Urol Nephrol; 2011 Feb; 45(1):46-51. PubMed ID: 20961268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canadian experience in sacral neuromodulation.
    Elkelini M; Hassouna MM
    Urol Clin North Am; 2005 Feb; 32(1):41-9. PubMed ID: 15698875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sacral versus pudendal nerve stimulation for voiding dysfunction: a prospective, single-blinded, randomized, crossover trial.
    Peters KM; Feber KM; Bennett RC
    Neurourol Urodyn; 2005; 24(7):643-7. PubMed ID: 16178000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving neuromodulation technique for refractory voiding dysfunctions: two-stage implant.
    Janknegt RA; Weil EH; Eerdmans PH
    Urology; 1997 Mar; 49(3):358-62. PubMed ID: 9123698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sacral nerve neuromodulation (InterStim). Part I: Review of the InterStim system.
    Rittenmeyer H
    Urol Nurs; 2008 Feb; 28(1):15-20. PubMed ID: 18335692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and management of malfunctioning sacral neuromodulator.
    Gaynor-Krupnick DM; Dwyer NT; Rittenmeyer H; Kreder KJ
    Urology; 2006 Feb; 67(2):246-9. PubMed ID: 16461074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reoperation after sacral neuromodulation therapy: a single-institution experience.
    Shih C; Miller JL; Fialkow M; Vicars BG; Yang CC
    Female Pelvic Med Reconstr Surg; 2013; 19(3):175-8. PubMed ID: 23611937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European experience with bilateral sacral neuromodulation in patients with chronic lower urinary tract dysfunction.
    van Kerrebroeck EV; Scheepens WA; de Bie RA; Weil EH
    Urol Clin North Am; 2005 Feb; 32(1):51-7. PubMed ID: 15698876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The presence of Fowler's syndrome predicts successful long-term outcome of sacral nerve stimulation in women with urinary retention.
    De Ridder D; Ost D; Bruyninckx F
    Eur Urol; 2007 Jan; 51(1):229-33; discussion 233-4. PubMed ID: 16860462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New sacral neuromodulation lead for percutaneous implantation using local anesthesia: description and first experience.
    Spinelli M; Giardiello G; Gerber M; Arduini A; van den Hombergh U; Malaguti S
    J Urol; 2003 Nov; 170(5):1905-7. PubMed ID: 14532804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of infections in patients undergoing staged implantation for sacral nerve stimulation.
    Guralnick ML; Benouni S; O'Connor RC; Edmiston C
    Urology; 2007 Jun; 69(6):1073-6. PubMed ID: 17572189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.